Navigation Links
ADHD Medications Don't Pose Cancer Risk
Date:11/21/2008

Study found 2 popular drugs do not cause genetic damage that can lead to disease

FRIDAY, Nov. 21 (HealthDay News) -- Two popular medications for treating attention-deficit hyperactivity disorder (ADHD) do not cause genetic damage linked to an increased risk for developing cancer, a new study says.

The study, done by researchers at Duke University Medical Center and the National Institutes of Health, counters a previous one that reported biomarkers associated with an increased cancer risk were present in the blood of children taking the ADHD drug methylphenidate.

"The new findings should help alleviate some of the concerns that were raised by the previous study," study co-author Scott Kollins, director of Duke's ADHD program, said in a university news release. "However, we need to continue to study the long-term effects of these medications and expand our analyses to include older patient populations."

The new study, which looked at methylphenidate (Ritalin LA and Concerta) and amphetamine (Adderall and Adderall XR), used a larger study sample and conditions that apply to a wider cross-section of children with ADHD than the initial study did, he said.

"We looked at three common markers associated with damaged chromosomes and did not find increased genetic abnormalities in children taking either medication, regardless of a variety of factors, such as age, sex, body weight, height, race or ADHD subtype," Kollins said.

About 2 million children have ADHD, a condition commonly characterized by inattention, hyperactivity and impulsivity. Methylphenidates and amphetamines have been used to treat the condition for decades, with millions of prescriptions written for them in the United States every year.

The study was published in the November online issue of the Journal of the American Academy of Child & Adolescent Psychiatry.

More information

The U.S. National Institute of Mental Health has more about ADHD.



-- Kevin McKeever



SOURCE: Duke University Medical Center, news release, Nov. 19, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
2. Naturally Safe Cold Remedy Challenges Effectiveness of Over-The-Counter Cold Medications
3. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
4. New Google Health Application Helps Users Find Patient Assistance Programs for Medications Using PatientAssistance.com
5. Anti-inflammatory medications may become a treatment for schizophrenia
6. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
7. Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications
8. Researchers examine safety of Internet prescriber service providing erectile dysfunction medications
9. Allergic-like reactions to iodinated contrast material treated safely with commonly used medications
10. Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications
11. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ADHD Medications Don't Pose Cancer Risk
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... , ... On Saturday, October 21, the Health & Wellness Center at Florida ... money for the American Heart Association Heart Walk. Teams of up to 10 people ... keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United ... year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and ... havens have extremely low property-tax rates, which contributes to the relatively lower cost ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vodori, Inc., ... promotional review platform at the Promotional Review Committee Compliance and Best Practices ... streamline the medical, legal, and regulatory review (MLR) process – which ensures ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... Mich. , Sept. 18, 2017  PMD Healthcare ... Specialty Pharmacy of Kalamazoo, Mich. , ... hub service that expedites and streamlines patient and provider ... PD 2.0, and wellness management services.  ... device used to measure lung function for a variety ...
Breaking Medicine Technology: